Owkin

News

Boehringer signs AI drug discovery deal with Owkin

Boehringer Ingelheim has joined Sanofi and AstraZeneca in signing up to deploy Owkin's AI platform K Pro in its drug discovery operations.

News

Scientists in a boat graphic from Owkin for ATLANTIS

Owkin launches ATLANTIS patient data mining project

Owkin has partnered 20 healthcare institutions on a patient data mining project, ATLANTIS, across oncology, immunology/inflammation, and neurology.

News

digital pathology slide from breast cancer screening

AZ and Owkin partner on AI to speed up BRCA testing

Testing for BRCA mutations linked to breast and ovarian cancers could become easier and more accessible with the help of artificial intelligence, potentially allowing earlier treatment.

News

Ex-BioMarin CEO Bienaimé re-emerges at Owkin

Just four months after ending an 18-year stint as chief executive of BioMarin, Jean-Jacques Bienaimé, has been named chairman of Owkin, a specialist in applying artificial

News

Prof Jean-Phillipe Vert, Owkin's chief R&D officer

Bioptimus born with $35m for a foundation model for biology

A team of scientists formerly working at Google DeepMind and Owkin have joined forces to create Bioptimus, a start-up that will apply generative artificial intelligence (G

News

Owkin and MSD join forces on AI-powered digital pathology

Pharma group MSD has joined forces with Owkin to develop artificial intelligence-powered digital pathology diagnostics that could be used to identify patients suitable for

Boehringer signs AI drug discovery deal with Owkin

Owkin launches ATLANTIS patient data mining project

AZ and Owkin partner on AI to speed up BRCA testing

Ex-BioMarin CEO Bienaimé re-emerges at Owkin

Bioptimus born with $35m for a foundation model for biology

Owkin and MSD join forces on AI-powered digital pathology

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Owkin

Editor's Picks